In conversation with Sue
The Passion in Building a Green and Sustainable Biological World
Sue Rees In Conversation with Joe Price Joe Price is the CEO, co-founder and commercialisation lead for early-stage biotech spinout Evolutor. The fledgling company has developed technology that streamlines and automates the process of optimising microbes for biomanufacturing. This includes products like bioethanol, bio-based chemicals, food ingredients, bioplastics, and many more. Joe is passionate about…
Read MoreThe business of visual communication for science
Sue Rees In conversation with Michal Barski of Reciprocal Space Dr Michal S Barski is the co-founder and director of Reciprocal Space, a visual science communications studio in London that designs effective visual marketing content for both start-ups and established biotech companies. Michal has a PhD in Structural Biology from the University of St Andrews…
Read MoreTaking the Plunge!
Sue Rees in conversation with Mike Davies Dr Mike Davies MD, FRCRS, FRSPSG is the founder and CEO of Manchester-based Carocell Bio. This startup biotech firm is developing novel peptides and a nanoparticle delivery system to get them into cells, switching off and preventing the activation of inflammation. This exciting new technology has the potential…
Read MoreWhat Does it Take to be One of the UK’s Coolest HealthTech Start-Ups?
Sue Rees in conversation with Mike Karim Mike Karim is the CEO of Oxford Endovascular, an exciting spin-out company from the University of Oxford. They are pioneering work in the prevention of brain haemorrhage by curing brain aneurysms, a condition that affects one in every 50 people. Their flagship product is the OxiFlow flow diverter,…
Read MoreIf You Can’t Measure it, You Can’t Improve it
Sue Rees in conversation with Peter Jenkins Peter Jenkins is the CEO of Infinitesima. Based near Oxford, it’s a privately owned company founded in 2001, as a spin-out of the University of Bristol, by CTO Professor Andrew Humphries. Peter leads a business that includes scientists and engineers who are focused on enabling the next generation…
Read MoreFever Pitch – Advice on how to make your biotech business attract more investors than you need
Sue Rees in conversation with Tony de Fougerolles The global pandemic has thrown up challenges for businesses worldwide, and some sectors reported difficulties in attracting the right (or any) investment or talent throughout 2020 and into 2021. However, one privately-held, Oxford-based biotech company has continued to go from strength to strength during one of the…
Read MoreWhen the going gets tough
Sue Rees in Conversation with Chris Busby ICE Oxford was founded in 2004 by Chris Busby and Paul Kelly to design and manufacture specialist Ultra-Low Temperature (ULT) and High Magnetic Field equipment for the cryogenic research community. Since then the company has grown to become a leading supplier of custom design, high-performance cryogenic systems to…
Read MoreBringing Common Sense to Tech Company Boardrooms
Tips for start-ups and early growth companies from a hugely successful serial entrepreneur I recently had the pleasure of chatting with Kevin Smith, a fellow Swansea native and fascinating business leader. Having been involved in the founding of six successful healthcare technology and wellbeing companies since the turn of the millennium, Kevin has learnt more…
Read MoreStarting a Company a Month Before Covid Hit
Sue Rees in conversation with Mark Preston Mark Preston is the CEO of Prismea, a biotech software development company that was founded in January 2020 – just a month before the UK entered its first lockdown due to COVID-19. Self-financed by Mark with his co-founder and CTO Andrew Smith, Prismea’s first product is SampleSafe.app that…
Read MoreCommercialised Science is a Team Sport
Sue Rees in conversation with Sarah Haywood Sarah Haywood is the Managing Director of Advanced Oxford, a not-for-profit membership group for innovating and disruptive businesses with strong ties to Oxfordshire. Describing herself to me with a smile as a “failed scientist”, Sarah has a biology degree from Oxford University, has been an NHS manager, Head…
Read More